Group sales of the first half-year of 2012 increased by EUR 11.2 million up to EUR 254.1 million

Offenburg, August 10, 2012 – MEDICLIN Aktiengesellschaft (MediClin) has achieved in the first half-year of 2012 Group sales of EUR 254.1 mill. which were EUR 11.2 mill. or 4.6 % higher than in the same period of last year. The main reason for the growth in sales was a marked rise in nursing days and in the number of cases − also the newly-created capacities are all well-utilised offering proof that the demand had been correctly assessed here.

The Group operating result of the first half-year of 2012 of EUR 1.1 mill. was EUR 0.7 mill. lower than in the same period of last year – or, adjusted for aperiodic releases of provisions contained in the previous year’s value, was EUR 2.1 mill. higher than the previous year’s value.

The financial result of the first half-year of 2012 of EUR -1.8 mill. improved by EUR 0.8 mill. in comparison with the same period in 2011 in response to lower interest expenses. The Group result attributable to shareholders of MediClin amounted to EUR -1.0 mill. (1 HY 2011: EUR -1.5 mill.).

In the first half-year of 2012, investments in non-current assets were made totalling a gross amount of EUR 11.2 mill. (1 HY 2011: EUR 11.3 mill.).

Post-acute segment records a result of EUR 1.3 mill.
As regards to the sales development in the segments, sales in the post-acute segment climbed by 7.2 % or EUR 9.8 mill. to EUR 145.5 mill. Sales in the acute segment of EUR 100.6 mill. remained approximately at the previous year’s level. This evidences that, in spite of the higher number of nursing days and cases, it was not possible to earn any surplus revenues. The nursing care business area contributed EUR 0.6 mill. to the sales increase, generating sales of EUR 6.4 mill. A look at the development of the result by segment shows the result in the post-acute segment of EUR 1.3 mill. to be EUR 3.9 mill. higher than the previous year’s value. In the acute segment it was not possible to compensate cost increases through additional sales so that a segment result of only EUR 3.9 mill. was achieved.

Outlook 2012
All in all the Management Board expects sales to rise and earnings to develop soundly in the financial year 2012 provided there are no fundamental changes to the conditions underlying the industry and to the referral behaviour of the coverage providers.

The interim report for the first-half year of 2012 is available under www.mediclin.de in German and English.

About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 11 Medizinische Versorgungs-zentren (medical care units) in 11 federal states MediClin has a total capacity of approxi¬mately 8,100 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,400 employees.